RIGEL PHARMACEUTICALS, INC. (RIGL)

46.48 -0.81% (-0.38)

Over 1M: +26.3%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

40 45
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 21.5M Q3 '21 — Operating Cash Flow: -10.3M Q3 '21 — Net Income: -21M Q4 '21 — Revenue: 20.4M Q4 '21 — Operating Cash Flow: -19.1M Q4 '21 — Net Income: -22.6M Q1 '22 — Revenue: 16.7M Q1 '22 — Operating Cash Flow: -25.6M Q1 '22 — Net Income: -27.4M Q2 '22 — Revenue: 29.8M Q2 '22 — Operating Cash Flow: -12.9M Q2 '22 — Net Income: -13.5M Q3 '22 — Revenue: 22.4M Q3 '22 — Operating Cash Flow: -13.3M Q3 '22 — Net Income: -19M Q4 '22 — Revenue: 51.3M Q4 '22 — Operating Cash Flow: -21.9M Q4 '22 — Net Income: 1.4M Q1 '23 — Revenue: 26.1M Q1 '23 — Operating Cash Flow: -4.1M Q1 '23 — Net Income: -13.5M Q2 '23 — Revenue: 26.9M Q2 '23 — Operating Cash Flow: 5.9M Q2 '23 — Net Income: -6.6M Q3 '23 — Revenue: 28.1M Q3 '23 — Operating Cash Flow: -1.4M Q3 '23 — Net Income: -5.7M Q4 '23 — Revenue: 35.8M Q4 '23 — Operating Cash Flow: -6.2M Q4 '23 — Net Income: 737K Q1 '24 — Revenue: 29.5M Q1 '24 — Operating Cash Flow: -5M Q1 '24 — Net Income: -8.2M Q2 '24 — Revenue: 36.8M Q2 '24 — Operating Cash Flow: 302K Q2 '24 — Net Income: -1M Q3 '24 — Revenue: 55.3M Q3 '24 — Operating Cash Flow: 21.7M Q3 '24 — Net Income: 12.4M Q4 '24 — Revenue: 57.6M Q4 '24 — Operating Cash Flow: 14.5M Q4 '24 — Net Income: 14.3M Q1 '25 — Revenue: 53.3M Q1 '25 — Operating Cash Flow: -893K Q1 '25 — Net Income: 11.4M Q2 '25 — Revenue: 101.7M Q2 '25 — Operating Cash Flow: 30.5M Q2 '25 — Net Income: 59.6M Q3 '25 — Revenue: 69.5M Q3 '25 — Operating Cash Flow: 24M Q3 '25 — Net Income: 27.9M Q4 '25 — Revenue: 69.8M Q4 '25 — Operating Cash Flow: 22M Q4 '25 — Net Income: 268.1M Q1 '26 — Revenue: 58.8M Q1 '26 — Operating Cash Flow: 2.7M Q1 '26 — Net Income: 8.7M Q2 '26 — Revenue: 78.7M Q2 '26 — Operating Cash Flow: 30.7M Q2 '26 — Net Income: 17.3M 0 60M 120M 180M 240M 300M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

6.2
OE margin 22.8%
Oper. margin 31.5%
ROIC 18.3%
FCF margin 28.7%
Gross margin 91.4%
Profit margin 116.3%
ROA 61.8%
ROCE 20.5%
ROE 75.7%
OCF margin 28.7%
OCF / EBIT 0.91×
Accruals 46.5%
Capex / sales —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.6
RPO / sales 0.0049×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.6
ND/EBITDA —
Cash / Debt 2.1×
Debt / Eq 0.11×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 1.8×
F-score 6.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.9
Sales CAGR 4Y +18.5%
Sales/sh Y/Y -3.0%
EPS Y/Y +208.9%
EBIT Y/Y -16.8%
Sales Q/Q -22.6%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.